#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous lupus erythematosus Pneumonia Subdural haematoma Muscular dystrophy Cystic fibrosis Oesophageal squamous cell carcinoma stage II Inclusion body myositis Chemical burn Gaucher's disease type I Graft versus host disease HER2 mutant non-small cell lung cancer Leukoencephalopathy Antiphospholipid syndrome Bronchiectasis Glycogen storage disease type V More trials…

    Learn about Rare Diseases

    Leiomyosarcoma recurrent – Basic Information Cytokine release syndrome – Trials in Disease Familial amyotrophic lateral sclerosis Chondrosarcoma – Trials in Disease Fragile X syndrome – Diagnostics Carcinoid syndrome – Treatment Hairy cell leukaemia recurrent Leiomyosarcoma – Life with Disease Hereditary neuropathic amyloidosis – Life with Disease Breast angiosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phenobarbital Allopurinol Sodium Insulin Human Amlodipine Besilate Benztropine Mesylate Riliprubart Dronabinol Poloxamer 407 Gandotinib Carbamazepine Laronidase Efepoetin Alfa Ademetionine Clic-1901 Cart Pravastatin Sodium Trametinib S095035 Bms-986435 Gozetotide Alf-18 SECRETIN SYNTHETIC HUMAN More therapies…

    Learn about Your Condition

    Biliary adenoma Malignant melanoma Kearns-Sayre syndrome Juvenile absence epilepsy Contusion Parkinson's disease Gastric cancer recurrent Lung adenocarcinoma stage III Implantation complication Ophthalmoplegia Mucopolysaccharidosis Mesothelioma Death neonatal Migraine Chronic disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A Study Testing Anti-CD19 CAR T-Cell Therapy in Patients with Systemic Sclerosis Who Did Not Respond to Immunosuppressive Drugs

    Recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    France

  • A Study of Repinatrabit Compared to Placebo for Treatment of Patients with Phenylketonuria

    Recruiting

    3 1
    Czechia France Germany Italy The Netherlands Poland +1

  • Long-Term Study of Vosoritide Safety and Effectiveness in Children with Hypochondroplasia Until Adult Height is Reached

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypochondroplasia
    Investigated Drugs:
    • Vosoritide
    France Germany Italy Spain

  • Testing trifluridine, tipiracil and nanoliposomal irinotecan combination for patients with bile duct or gallbladder cancer after previous treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    • Gallbladder cancer
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    • Irinotecan
    Germany

  • Testing dehydroepiandrosterone combined with standard antidepressants for patients with treatment-resistant depression

    Recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Prasterone
    • Lactose Monohydrate
    Germany

  • Study of lidocaine to reduce opioid use in patients with sickle cell disease experiencing severe pain crisis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Sodium Chloride
    France
Previous Page
1 … 107 108 109 110 111 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!